Klaus Sindahl
Investor Relations Contact at HANSA BIOPHARMA AB
Network origin in Klaus Sindahl first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.
40
| Extinct | Chemicals: Specialty | 40 |
| Public Company | Pharmaceuticals: Major | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Klaus Sindahl via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Technical University of Denmark | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Director/Board Member Doctorate Degree Graduate Degree Doctorate Degree | |
| ROCKWOOL A/S | Construction Materials | Director/Board Member Chairman Public Communications Contact | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| University of Aarhus | College/University | Director/Board Member Doctorate Degree Graduate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Director of Finance/CFO Director/Board Member General Counsel | |
| CORBION N.V. | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ORSTED A/S | Electric Utilities | Chairman Public Communications Contact | |
| BIOGAIA AB | Pharmaceuticals: Other | Director/Board Member Founder | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
| AMYRIS, INC. | Chemicals: Specialty | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director of Finance/CFO Director/Board Member | |
New Xellia Group A/S
 New Xellia Group A/S Financial ConglomeratesFinance New Xellia Group A/S operates as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SCANDINAVIAN INVESTMENT GROUP A/S | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Chief Executive Officer | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Biosyntia ApS
 Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member | |
| University of Uppsala | College/University | Corporate Officer/Principal Graduate Degree | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALFA LAVAL AB | Industrial Machinery | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| CONVATEC GROUP PLC | Medical Specialties | Director/Board Member | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
Moelis & Co. LLC
 Moelis & Co. LLC Investment Banks/BrokersFinance Founded in 2007, Moelis & Co. LLC is a registered broker/dealer headquartered in New York City. The firm is a subsidiary of Moelis & Company (NYSE: MC), a global investment bank that provides financial advisory, capital raising and asset management services to corporations, institutions and governments. Moelis & Co. LLC provides an array of trading and execution services for their clients. They do not provide any internal research. | Investment Banks/Brokers | Corporate Officer/Principal | |
Moelis Asset Management LP
 Moelis Asset Management LP Investment Banks/BrokersFinance Moelis Asset Management LP provides investment banking services. It capabilities include private equity, credit and structured products. The company was founded by Ken Moelis in 2007 and is headquartered in New York, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Arts Biologics A/S | Director/Board Member |
Statistics
International
| Denmark | 22 |
| United States | 10 |
| Sweden | 9 |
| Switzerland | 5 |
| United Kingdom | 5 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Finance | 8 |
| Consumer Non-Durables | 4 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 250 |
| Corporate Officer/Principal | 129 |
| Chairman | 83 |
| Independent Dir/Board Member | 64 |
| Chief Executive Officer | 40 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Erik Mathias Uhlén | 32 |
| Agnete Raaschou-Nielsen | 32 |
| Eva Nilsagård | 30 |
| Lena Marie Olving Öhberg | 30 |
| Ulf Arne Wiinberg | 26 |
| Walther Thygesen | 25 |
| Anders Gersel Pedersen | 24 |
| Jörgen Axel Thorball | 24 |
| Steen Riisgaard | 24 |
| Søren Møller | 21 |
| Kasim Kutay | 21 |
| Jørgen Buhl Rasmussen | 18 |
| Per Falholt | 18 |
| Benny Dalgaard Loft | 16 |
| Mats Blom | 15 |
- Stock Market
- Insiders
- Klaus Sindahl
- Company connections
